172 related articles for article (PubMed ID: 10037194)
1. Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoids.
Sun SY; Kurie JM; Yue P; Dawson MI; Shroot B; Chandraratna RA; Hong WK; Lotan R
Clin Cancer Res; 1999 Feb; 5(2):431-7. PubMed ID: 10037194
[TBL] [Abstract][Full Text] [Related]
2. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
[TBL] [Abstract][Full Text] [Related]
3. Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors.
Kim YH; Dohi DF; Han GR; Zou CP; Oridate N; Walsh GL; Nesbitt JC; Xu XC; Hong WK; Lotan R
Cancer Res; 1995 Dec; 55(23):5603-10. PubMed ID: 7585641
[TBL] [Abstract][Full Text] [Related]
4. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.
Le Q; Dawson MI; Soprano DR; Soprano KJ
Oncogene; 2000 Mar; 19(11):1457-65. PubMed ID: 10723137
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
Sun SY; Yue P; Dawson MI; Shroot B; Michel S; Lamph WW; Heyman RA; Teng M; Chandraratna RA; Shudo K; Hong WK; Lotan R
Cancer Res; 1997 Nov; 57(21):4931-9. PubMed ID: 9354460
[TBL] [Abstract][Full Text] [Related]
6. Growth suppression of transformed human bronchial epithelial cells by all-trans-retinoic acid occurs through specific retinoid receptors.
Ahn MJ; Langenfeld J; Moasser MM; Rusch V; Dmitrovsky E
Oncogene; 1995 Dec; 11(11):2357-64. PubMed ID: 8570187
[TBL] [Abstract][Full Text] [Related]
7. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
Kumar A; Soprano DR; Parekh HK
Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
Lee HY; Dawson MI; Walsh GL; Nesbitt JC; Eckert RL; Fuchs E; Hong WK; Lotan R; Kurie JM
Cell Growth Differ; 1996 Aug; 7(8):997-1004. PubMed ID: 8853895
[TBL] [Abstract][Full Text] [Related]
9. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
Schneider SM; Offterdinger M; Huber H; Grunt TW
Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
[TBL] [Abstract][Full Text] [Related]
10. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB
Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis in ovarian carcinoma cells by AHPN/CD437 is mediated by retinoic acid receptors.
Holmes WF; Dawson MI; Soprano RD; Soprano KJ
J Cell Physiol; 2000 Oct; 185(1):61-7. PubMed ID: 10942519
[TBL] [Abstract][Full Text] [Related]
12. Retinoids and malignant melanoma: a pathway of proliferation inhibition on SK MEL28 cell line.
Emionite L; Galmozzi F; Raffo P; Vergani L; Toma S
Anticancer Res; 2003; 23(1A):13-9. PubMed ID: 12680189
[TBL] [Abstract][Full Text] [Related]
13. Differential response of normal, premalignant and malignant human oral epithelial cells to growth inhibition by chemopreventive agents.
D'Ambrosio SM; Gibson-D'Ambrosio R; Milo GE; Casto B; Kelloff GJ; Steele VE
Anticancer Res; 2000; 20(4):2273-80. PubMed ID: 10953285
[TBL] [Abstract][Full Text] [Related]
14. The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells.
Sun SY; Yue P; Chen X; Hong WK; Lotan R
Cancer Res; 2002 Apr; 62(8):2430-6. PubMed ID: 11956107
[TBL] [Abstract][Full Text] [Related]
15. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
Afonja O; Juste D; Das S; Matsuhashi S; Samuels HH
Oncogene; 2004 Oct; 23(49):8135-45. PubMed ID: 15361828
[TBL] [Abstract][Full Text] [Related]
16. Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockade.
Wu K; DuPré E; Kim H; Tin-U CK; Bissonnette RP; Lamph WW; Brown PH
Breast Cancer Res Treat; 2006 Mar; 96(2):147-57. PubMed ID: 16273314
[TBL] [Abstract][Full Text] [Related]
17. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
[TBL] [Abstract][Full Text] [Related]
18. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells.
Lehmann S; Paul C; Törmä H
Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892
[TBL] [Abstract][Full Text] [Related]
19. Posttranslational mechanisms contribute to the suppression of specific cyclin:CDK complexes by all-trans retinoic acid in human bronchial epithelial cells.
Sueoka N; Lee HY; Walsh GL; Hong WK; Kurie JM
Cancer Res; 1999 Aug; 59(15):3838-44. PubMed ID: 10447003
[TBL] [Abstract][Full Text] [Related]
20. Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization.
Jiang SY; Shen SR; Shyu RY; Yu JC; Harn HJ; Yeh MY; Lee MM; Chang YC
Br J Cancer; 1999 Apr; 80(1-2):206-14. PubMed ID: 10389997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
